§ BIOTECHNOLOGY
USD · BiotechnologyIMRX
IMMUNEERING CORP - CLASS A
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
77 increased/new, 24 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 9.7M | 0.0% | +0% |
| Sanofi | 2.7M | 4.2% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | n/a | n/a |
| Marshall Wace LLP | 2.0M | 0.0% | +180% |
| BlackRock, Inc. | 1.5M | 0.0% | +4% |
| Millennium Management | 1.1M | 0.0% | +2065% |
◇ AC INTELLIGENCE
Top institutional owners for IMRX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER54.2% · 0 holders
OTHER18.1% · 64 holders
QUALITY / COMPOUNDER15.1% · 3 holders
SYSTEMATIC / QUANT3.6% · 5 holders
PASSIVE / INDEX3.4% · 3 holders
DEALER / BANK2.8% · 15 holders
TACTICAL / MACRO2.7% · 3 holders
INCOME / DEFENSIVE0.1% · 1 holder
DEEP VALUE0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for IMRX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention IMRX yet.